Caricamento...
Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
BACKGROUND: Active surveillance (AS) is recommended by most national medical organizations as the preferred treatment option for men with low-risk prostate cancer (PCa). However, studies report that up to one third of men on AS dropout within 5 years, without evidence of disease progression. Despite...
Salvato in:
| Pubblicato in: | Transl Androl Urol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8261438/ https://ncbi.nlm.nih.gov/pubmed/34295758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1254 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|